Literature DB >> 17491016

Novel role of Y1 receptors in the coordinated regulation of bone and energy homeostasis.

Paul A Baldock1, Susan J Allison, Pernilla Lundberg, Nicola J Lee, Katy Slack, En-Ju D Lin, Ronaldo F Enriquez, Michelle M McDonald, Lei Zhang, Matthew J During, David G Little, John A Eisman, Edith M Gardiner, Ernie Yulyaningsih, Shu Lin, Amanda Sainsbury, Herbert Herzog.   

Abstract

The importance of neuropeptide Y (NPY) and Y2 receptors in the regulation of bone and energy homeostasis has recently been demonstrated. However, the contributions of the other Y receptors are less clear. Here we show that Y1 receptors are expressed on osteoblastic cells. Moreover, bone and adipose tissue mass are elevated in Y1(-/-) mice with a generalized increase in bone formation on cortical and cancellous surfaces. Importantly, the inhibitory effects of NPY on bone marrow stromal cells in vitro are absent in cells derived from Y1(-/-) mice, indicating a direct action of NPY on bone cells via this Y receptor. Interestingly, in contrast to Y2 receptor or germ line Y1 receptor deletion, conditional deletion of hypothalamic Y1 receptors in adult mice did not alter bone homeostasis, food intake, or adiposity. Furthermore, deletion of both Y1 and Y2 receptors did not produce additive effects in bone or adiposity. Thus Y1 receptor pathways act powerfully to inhibit bone production and adiposity by nonhypothalamic pathways, with potentially direct effects on bone tissue through a single pathway with Y2 receptors.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17491016     DOI: 10.1074/jbc.M700644200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

Review 1.  The hunger games of skeletal metabolism.

Authors:  Natalie K Y Wee; Paul A Baldock
Journal:  Bonekey Rep       Date:  2014-11-12

Review 2.  Osteoblastic Actions of the Neuropeptide Y System to Regulate Bone and Energy Homeostasis.

Authors:  Harry Horsnell; Paul A Baldock
Journal:  Curr Osteoporos Rep       Date:  2016-02       Impact factor: 5.096

Review 3.  Signaling networks that control the lineage commitment and differentiation of bone cells.

Authors:  Carrie S Soltanoff; Shuying Yang; Wei Chen; Yi-Ping Li
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

Review 4.  Influence of hormonal appetite and energy regulators on bone.

Authors:  Ee Cheng Khor; Natalie Kah Yun Wee; Paul A Baldock
Journal:  Curr Osteoporos Rep       Date:  2013-09       Impact factor: 5.096

Review 5.  The multiple faces of autoimmune-mediated bone loss.

Authors:  Georg Schett; Jean-Pierre David
Journal:  Nat Rev Endocrinol       Date:  2010-11-02       Impact factor: 43.330

6.  NPY receptors as potential targets for anti-obesity drug development.

Authors:  Ernie Yulyaningsih; Lei Zhang; Herbert Herzog; Amanda Sainsbury
Journal:  Br J Pharmacol       Date:  2011-07       Impact factor: 8.739

Review 7.  Bone, brain & beyond.

Authors:  Alexandre Chamouni; Christiane Schreiweis; Franck Oury
Journal:  Rev Endocr Metab Disord       Date:  2015-06       Impact factor: 6.514

Review 8.  Endocrine regulation of bone and energy metabolism in hibernating mammals.

Authors:  Alison H Doherty; Gregory L Florant; Seth W Donahue
Journal:  Integr Comp Biol       Date:  2014-02-19       Impact factor: 3.326

9.  Neuropeptide Y knockout mice reveal a central role of NPY in the coordination of bone mass to body weight.

Authors:  Paul A Baldock; Nicola J Lee; Frank Driessler; Shu Lin; Susan Allison; Bernhard Stehrer; En-Ju D Lin; Lei Zhang; Ronald F Enriquez; Iris P L Wong; Michelle M McDonald; Matthew During; Dominique D Pierroz; Katy Slack; Yan C Shi; Ernie Yulyaningsih; Aygul Aljanova; David G Little; Serge L Ferrari; Amanda Sainsbury; John A Eisman; Herbert Herzog
Journal:  PLoS One       Date:  2009-12-22       Impact factor: 3.240

10.  Quantitative analysis of neuropeptide Y receptor association with beta-arrestin2 measured by bimolecular fluorescence complementation.

Authors:  L E Kilpatrick; S J Briddon; S J Hill; N D Holliday
Journal:  Br J Pharmacol       Date:  2010-04-28       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.